Clinical outcomes (death and lost to follow-up [LTFU]) during the first ten years of HAART among all patients who initiated HAART prior to 2004 at six CCASAnet sites (n = 4975).

<p>Median (black line) as well as 25^th and 75^th percentile CD4 counts (white lines) are also displayed. The percentage of active patients with a measured viral load and CD4 is given at the bottom of the figure. The proportions for viral load categories are based on the relative frequency of each category among active patients with a measurement during the six-month period. Haiti site didn´t measure viral load.</p

Drug regimen status during the first ten years of HAART among all patients who initiated treatment prior to 2004 (n = 4,975).

<p>Drug regimen status during the first ten years of HAART among all patients who initiated treatment prior to 2004 (n = 4,975).</p

Demographic and physiological characteristics for patients initiating antiretroviral therapy across six Caribbean, Central and South America sites (N = 4975).

<p>Demographic and physiological characteristics for patients initiating antiretroviral therapy across six Caribbean, Central and South America sites (N = 4975).</p